Norethindrone/Ethinyl Estradiol

炔诺酮/炔雌醇

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameNorethindrone/Ethinyl Estradiol
Drug Alias Name复方炔诺酮
ClassificationSmall molecules
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsProgesterone receptorEstrogen receptors
Therapy Area/IndicationsVasomotor symptomContraceptionAcne Vulgaris +[5] 
Global Approved IndicationsContraception
Approved Indications in ChinaContraception
Original Approved Country/TerritoryUnited States
Original Approved Date1973/04/30
Country/TerritoryUnited StatesMainland China
CombinationsYes NorethindroneEthinyl Estradiol
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWarner Chilcott LtdShanghai Sine Tianping Pharmaceutical Co Ltd
Inactive CompaniesTeva Branded Pharmaceutical Products R&D IncAllergan Pharmaceuticals International Ltd
Active IndicationsVasomotor symptomContraceptionVascular Diseases +[4] 
Inactive IndicationsAcne Vulgaris

Other Information

ATC CodeG03AA05G03AB04
Related LinksN/A